Stone Clearance With Aspiration vs Other Technologies: a Real-world Evidence Study
Launched by CALYXO, INC. ·
Trial Information
Current as of November 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how well a new method called SURE with the CVAC System works to remove kidney stones compared to other common treatments. Kidney stones are hard deposits that form in the kidneys and can cause pain or other problems. This study will focus on people who are already candidates for a common procedure called ureteroscopy (URS) with laser lithotripsy, which is a way to break up and remove stones using a small camera and laser.
People between the ages of 65 and 74, of any gender, who have kidney stones and are eligible for URS with laser treatment may be able to join this trial. Participants will receive treatment using either the new SURE method or other standard technologies, and the study will compare how well each approach clears the stones. This trial is not yet recruiting, so those interested should stay in touch with their healthcare provider for updates. The main goal is to find out which treatment works best in real-world settings to help patients have their kidney stones removed effectively and safely.
Gender
ALL
Eligibility criteria
About Calyxo, Inc.
Calyxo, Inc. is a biopharmaceutical company dedicated to advancing innovative therapies for the treatment of complex diseases. With a focus on harnessing cutting-edge research and development, Calyxo aims to improve patient outcomes through its commitment to scientific excellence and rigorous clinical trials. The company prioritizes collaboration with healthcare professionals and stakeholders to ensure that its therapeutic solutions address unmet medical needs effectively. Through its pipeline of promising candidates, Calyxo, Inc. strives to contribute to the future of medicine by transforming scientific discoveries into tangible health solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported